AustralianSuper’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$988K Hold
15,725
0.01% 266
2025
Q4
$1.04M Hold
15,725
﹤0.01% 260
2025
Q3
$1.06M Hold
15,725
0.01% 253
2025
Q2
$1.37M Hold
15,725
0.01% 235
2025
Q1
$1.07M Hold
15,725
0.01% 201
2024
Q4
$1.22M Hold
15,725
0.01% 197
2024
Q3
$1.05M Buy
15,725
+5,568
+55% +$457K 0.01% 209
2024
Q2
$1.15M Hold
10,157
0.01% 200
2024
Q1
$1.4M Hold
10,157
0.01% 193
2023
Q4
$1.26M Hold
10,157
0.01% 217
2023
Q3
$948K Buy
10,157
+501
+5% +$56.5K 0.01% 217
2023
Q2
$1.24M Buy
+9,656
New +$1.17M 0.01% 221
2020
Q3
Sell
-66,280
Closed -$6.72M 158
2020
Q2
$6.72M Buy
+66,280
New +$5.93M 0.07% 114

Other funds holding DXCM

AustralianSuper's DXCM Position: Q1 2026 in Review

AustralianSuper held its DexCom (DXCM) position steady in Q1 2026 at 15,725 shares worth $988K. The position accounts for 0.01% of the portfolio, ranked #266.

AustralianSuper first reported a position in DXCM in Q2 2020 and has held it in 13 quarters since. The position peaked at $6.72M in Q2 2020. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • AustralianSuper held 15,725 shares of DexCom worth $988K as of Q1 2026.
  • AustralianSuper left its DexCom share count unchanged in Q1 2026.
  • DexCom made up 0.01% of AustralianSuper's portfolio in Q1 2026, its #266 holding.
  • AustralianSuper first reported a position in DexCom in Q2 2020 and has held it in 13 quarters since.
  • AustralianSuper's DexCom position peaked at $6.72M in Q2 2020.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on AustralianSuper's 13F filing for Q1 2026, filed 7 May 2026.